Abstract 3359: Maspin induces MET in prostate cancer cells cultured in 3D-collagen I

Author(s):  
Ivory Dean ◽  
Margarida Bernardo ◽  
Xiaohua Li ◽  
Sijana Dzinic ◽  
Shuping Yin ◽  
...  
PLoS ONE ◽  
2013 ◽  
Vol 8 (3) ◽  
pp. e57706 ◽  
Author(s):  
Ediz Sariisik ◽  
Denitsa Docheva ◽  
Daniela Padula ◽  
Cvetan Popov ◽  
Jan Opfer ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e111029 ◽  
Author(s):  
Karen F. Chambers ◽  
Eman M. O. Mosaad ◽  
Pamela J. Russell ◽  
Judith A. Clements ◽  
Michael R. Doran

1991 ◽  
Vol 145 (3) ◽  
pp. 624-630 ◽  
Author(s):  
Donna M. Peehl ◽  
Stephen T. Wong ◽  
Thomas A. Stamey

2014 ◽  
Vol 62 (44) ◽  
pp. 10752-10758 ◽  
Author(s):  
Huarong Huang ◽  
Yan He ◽  
Xiao-Xing Cui ◽  
Susan Goodin ◽  
Hong Wang ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0125641 ◽  
Author(s):  
Karen F. Chambers ◽  
Eman M. O. Mosaad ◽  
Pamela J. Russell ◽  
Judith A. Clements ◽  
Michael R. Doran

2007 ◽  
Vol 35 (4) ◽  
pp. 701-703 ◽  
Author(s):  
I. Podgorski ◽  
B.E. Linebaugh ◽  
B.F. Sloane

The skeleton is the most common site of metastasis in patients with advanced prostate cancer. Despite many advances in targeting skeletal metastases, the mechanisms behind the attraction of prostate cancer cells to the bone are not known. Osteoclast cathepsin K, due to its ability to effectively degrade bone matrix collagen I, has been implicated in colonization and growth of prostate tumours in the bone. Identification of new cathepsin K substrates in the bone microenvironment and the recent findings demonstrating its involvement in obesity and inflammation suggest additional roles for this enzyme in skeletal metastases of prostate cancer.


2007 ◽  
Vol 177 (4S) ◽  
pp. 93-93
Author(s):  
Makoto Sumitomo ◽  
Kenji Kuroda ◽  
Takako Asano ◽  
Akio Horiguchi ◽  
Keiichi Ito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document